NHI.no
Annonse
Informasjon, tilstand

Rosen (erysipelas)

Rosen (erysipelas) er en avgrenset betennelse i huden som sprer seg i de mer overflatiske hudlagene og lymfebanene. Vanlige symptomer er utslett som er rødt og hevet over resten av huden, varmeøkning, smerte, ømme lymfeknuter og feber.

Rosen er vanligvis forårsaket av bakterien gruppe A streptokokker (GAS).

Sist oppdatert:

8. jan. 2021

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Erysipelas . Referanselisten for dette dokumentet vises nedenfor

  1. Helsedirektoratet (2021). Nasjonal faglig retningslinje for antibiotika i primærhelsetjenesten nettdokument. Oslo: Helsedirektoratet (sist faglig oppdatert 16. november 2021, lest jan 2022).
  2. Bläckberg A, Trell K, Rasmussen M. Erysipelas, a large retrospective study of aetiology and clinical presentation. BMC Infect Dis. 2015 Sep 30;15:402. PMID: 26424182. PubMed
  3. Bruun T, Oppegaard O, Kittang BR, et al. Etiology of Cellulitis and Clinical Prediction of Streptococcal Disease: A Prospective Study. Open Forum Infect Dis. 2015 Nov 25;3(1):ofv181. PMID: 26734653.
  4. Hirschmann JV, Raugi GJ. Lower limb cellulitis and its mimics: part I. Lower limb cellulitis. J Am Acad Dermatol 2012; 67: 163. pmid:22794815 PubMed
  5. Oppegaard O, Mylvaganam H, Kittang BR. Beta-haemolytic group A, C and G streptococcal infections in Western Norway: a 15-year retrospective survey. Clin Microbiol Infect. 2015 Feb;21(2):171-8. Epub 2014 Oct 14. PMID: 25658557. PubMed
  6. Goettsch WG, Bouwes Bavinck JN, Herings RM. Burden of illness of bacterial cellulitis and erysipelas of the leg in the Netherlands. J Eur Acad Dermatol Venereol 2006;20:834-839. PubMed
  7. McNamara DR, Tleyjeh IM, Berbari EF. Incidence of lower-extremity cellulitis: a population-based study in Olmsted county, Minnesota. Mayo Clin Proc 2007; 82: 817. pmid:17605961 PubMed
  8. Norsk barnelegeforening, pediatriveileder: Erysipelas (Rosen). Sist revidert 2012. Nettsiden besøkt 04.01.21. www.helsebiblioteket.no
  9. Rath E, Skrede S, Mylvaganam H, Bruun T. Aetiology and clinical features of facial cellulitis: a prospective study. Infect Dis (Lond). 2018 Jan;50(1):27-34. Epub 2017 Aug 2. PMID: 28768452. PubMed
  10. Gunderson CG, Martinello RA. A systematic review of bacteremias in cellulitis and erysipelas. J Infect 2012;64:148-155. PubMed
  11. Jeng A, Beheshti M, Li J, Nathan R. The role of beta-hemolytic streptococci in causing diffuse, nonculturable cellulitis: a prospective investigation. Medicine 2010; 89: 217-26. PubMed
  12. Trell K, Rignér S, Wierzbicka M, Nilson B, Rasmussen M. Colonization of β-hemolytic streptococci in patients with erysipelas-a prospective study. Eur J Clin Microbiol Infect Dis. 2019 Oct;38(10):1901-1906. Epub 2019 Jul 10. PMID: 31292789. PubMed
  13. Eriksson BKG, Karkkonen K, Jorup-Rönström C, Wretlind B. Frequent colonization of betahaemolytic streptococci at various body sites including the perineum and anal canal during erysipelas and cellulitis. Infect Dis (Lond). 2019 Jul;51(7):534-540. Epub 2019 May 15. PMID: 31088328. PubMed
  14. Dupuy A, Benchikhi H, Roujeau J-C, et al. Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ 1999; 318: 1591-4. British Medical Journal
  15. Cranendonk DR, Lavrijsen APM, Prins JM, Wiersinga WJ. Cellulitis: current insights into pathophysiology and clinical management. Neth J Med. 2017 Nov;75(9):366-378. PMID: 29219814. PubMed
  16. Stevens DL, Bisno AL, Chambers HF. Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America. Clin Infect Dis 2014; 59: e10. pmid:24973422 PubMed
  17. Rath E, Skrede S, Oppegaard O, Bruun T. Non-purulent skin and soft tissue infections: predictive power of a severity score and the appropriateness of treatment in a prospective cohort. Infect Dis (Lond). 2020 May;52(5):361-371. Epub 2020 Feb 13. PMID: 32052670. PubMed
  18. Bruun T, Oppegaard O, Hufthammer KO, et al. Early Response in Cellulitis: A Prospective Study of Dynamics and Predictors. Clin Infect Dis. 2016 Oct 15;63(8):1034-1041. Epub 2016 Jul 11. PMID: 27402819. PubMed
  19. Brindle R.J, O’Neill L.A, Williams OM. Risk, Prevention, Diagnosis, and Management of Cellulitis and Erysipelas. Curr Derm Rep 9, 73–82 (2020). https://doi.org/10.1007/s13671-020-00287-1
  20. Webb E, Neeman T, Bowden F, et al. Compression Therapy to Prevent Recurrent Cellulitis of the Leg. N Engl J Med 2020; 383: 630-639. doi:10.1056/NEJMoa1917197 DOI
  21. Peghin M, Graziano E, Rovelli C, Grossi PA. Prevention and treatment of recurrent cellulitis. Curr Opin Infect Dis. 2023 Apr 1;36(2):95-101. Epub 2023 Feb 9. PMID: 36853755 PubMed
  22. Helsedirektoratet. Erysipelas. Nasjonal faglig retningslinje for bruk av antibiotika i sykehus. Sist faglig oppdatert jan. 2018. Siden lest 16.11.2020. www.helsedirektoratet.no
  23. Inghammar M, Rasmussen M, Linder A. Recurrent erysipelas--risk factors and clinical presentation. BMC Infect Dis. 2014 May 18;14:270. PMID: 24884840. PubMed
  24. Oppegaard O, Skrede S, Mylvaganam H, Kittang BR. Emerging Threat of Antimicrobial Resistance in β-Hemolytic Streptococci. Front Microbiol. 2020 May 15;11:797. PMID: 32477287. PubMed
Annonse
Annonse